Although our observation of higher short-chain MTX-Glu levels in CD in remission compared to active CD did not reach statistical significance ( p = 0.066), this is likely due to limitations in the sample size and further obscured by participants receiving concomitant IFX therapy, as suggested by our multivariable regression analysis.
← all excerpts
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease.
2
0.0660
0.0660
The sentences
a positive trendp = 0.066
Looking only at children with Crohn’s disease ( n = 19), a positive trend toward higher short-chain MTX-Glu n concentrations was observed in children with remission vs. active disease, approaching statistical significance ( p = 0.066).